IsoPlexis Profit Margin

IsoPlexis (ISO) currently reports a profit margin of -663.5% as of December 2022. That compares with -567.49% in the prior-year period — down 16.9% year over year. That is below the Healthcare sector average of 19.13%. Use the charts on this page to explore IsoPlexis's profit margin history and peer comparisons.

IsoPlexis's profit margin decreased from -567.49% to -663.5% — a 16.9% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

IsoPlexis's profit margin of -663.5% is lower than the Healthcare sector average of 19.13%. That is roughly 3568.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but IsoPlexis's current -663.5% should be judged against Healthcare norms (sector average: 19.13%) and against ISO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -663.5%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 19.13%. From there, open related valuation or income-statement pages for IsoPlexis, and consider following ISO for alerts when major investors trade the stock.